Filed: 8/15/2024ACC: 0001420506-24-001576
📋 What this filing means
ALTIUM CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 66 equity positions with a total reported market value of $245.12M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
66
Positions
$245.12M
Total AUM (reported)
52.67M
Total Shares
Allocation by class
COM$122.15M49.8%
COM NEW$43.59M17.8%
CL A$33.39M13.6%
SPONSORED ADR$16.71M6.8%
COM PAR $.01$12.73M5.2%
COM SHS$9.68M3.9%
CLASS A ORD$5.06M2.1%
Portfolio Concentration
Top 3$56.77M23.2%
4–10$80.23M32.7%
11–25$88.27M36.0%
Rest$19.84M8.1%
Top 3 weight
23.2%
Top 10 weight
55.9%
Voting Authority Distribution
Total shares with voting rights: 52.26M
Sole
Full voting authority
52.26M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole66
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings66
Rows:
VERA THERAPEUTICS INC
SOLEShares714K
TypeSH
Market value$25.83M
10.54%
Sole
714K
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares1.51M
TypeSH
Market value$16.88M
6.89%
Sole
1.51M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares360.60K
TypeSH
Market value$14.06M
5.74%
Sole
360.60K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares193K
TypeSH
Market value$13.22M
5.39%
Sole
193K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares81.90K
TypeSH
Market value$12.94M
5.28%
Sole
81.90K
Shared
0.00
None
0.00
INSMED INC
SOLEShares190K
TypeSH
Market value$12.73M
5.19%
Sole
190K
Shared
0.00
None
0.00
ALIMERA SCIENCES INC
SOLEShares2.15M
TypeSH
Market value$11.95M
4.88%
Sole
2.15M
Shared
0.00
None
0.00
SKYE BIOSCIENCE INC
SOLEShares1.35M
TypeSH
Market value$10.81M
4.41%
Sole
1.35M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares23K
TypeSH
Market value$9.89M
4.04%
Sole
23K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares212.91K
TypeSH
Market value$8.69M
3.54%
Sole
212.91K
Shared
0.00
None
0.00
AVADEL PHARMACEUTICALS PLC
SOLEShares610K
TypeSH
Market value$8.58M
3.50%
Sole
610K
Shared
0.00
None
0.00
CATALYST PHARMACEUTICALS INC
SOLEShares500K
TypeSH
Market value$7.75M
3.16%
Sole
500K
Shared
0.00
None
0.00
CONTINEUM THERAPEUTICS INC
SOLEShares429.34K
TypeSH
Market value$7.56M
3.08%
Sole
429.34K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.70M
TypeSH
Market value$7.31M
2.98%
Sole
1.70M
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares50K
TypeSH
Market value$6.82M
2.78%
Sole
50K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares122K
TypeSH
Market value$6.47M
2.64%
Sole
122K
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
SOLEShares889K
TypeSH
Market value$6.45M
2.63%
Sole
693K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares1.59M
TypeSH
Market value$6.43M
2.62%
Sole
1.57M
Shared
0.00
None
0.00
ZEVRA THERAPEUTICS INC
SOLEShares1.16M
TypeSH
Market value$5.70M
2.32%
Sole
1.16M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares115K
TypeSH
Market value$5.06M
2.06%
Sole
115K
Shared
0.00
None
0.00
XTANT MED HLDGS INC
SOLEShares7.42M
TypeSH
Market value$4.67M
1.91%
Sole
7.42M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares50K
TypeSH
Market value$4.03M
1.64%
Sole
50K
Shared
0.00
None
0.00
THE REALREAL INC
SOLEShares1.25M
TypeSH
Market value$3.99M
1.63%
Sole
1.25M
Shared
0.00
None
0.00
CYBIN INC
SOLEShares13.95M
TypeSH
Market value$3.78M
1.54%
Sole
13.95M
Shared
0.00
None
0.00
OUTLOOK THERAPEUTICS INC
SOLEShares501.79K
TypeSH
Market value$3.70M
1.51%
Sole
501.79K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VERA THERAPEUTICS INCSOLE | CL A | 714K | SH | $25.83M 10.54% | 714K | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 1.51M | SH | $16.88M 6.89% | 1.51M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 360.60K | SH | $14.06M 5.74% | 360.60K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 193K | SH | $13.22M 5.39% | 193K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 81.90K | SH | $12.94M 5.28% | 81.90K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 190K | SH | $12.73M 5.19% | 190K | 0.00 | 0.00 |
ALIMERA SCIENCES INCSOLE | COM NEW | 2.15M | SH | $11.95M 4.88% | 2.15M | 0.00 | 0.00 |
SKYE BIOSCIENCE INCSOLE | COM NEW | 1.35M | SH | $10.81M 4.41% | 1.35M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 23K | SH | $9.89M 4.04% | 23K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 212.91K | SH | $8.69M 3.54% | 212.91K | 0.00 | 0.00 |
AVADEL PHARMACEUTICALS PLCSOLE | COM SHS | 610K | SH | $8.58M 3.50% | 610K | 0.00 | 0.00 |
CATALYST PHARMACEUTICALS INCSOLE | COM | 500K | SH | $7.75M 3.16% | 500K | 0.00 | 0.00 |
CONTINEUM THERAPEUTICS INCSOLE | CL A | 429.34K | SH | $7.56M 3.08% | 429.34K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.70M | SH | $7.31M 2.98% | 1.70M | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 50K | SH | $6.82M 2.78% | 50K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 122K | SH | $6.47M 2.64% | 122K | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCSOLE | COM | 889K | SH | $6.45M 2.63% | 693K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 1.59M | SH | $6.43M 2.62% | 1.57M | 0.00 | 0.00 |
ZEVRA THERAPEUTICS INCSOLE | COM NEW | 1.16M | SH | $5.70M 2.32% | 1.16M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 115K | SH | $5.06M 2.06% | 115K | 0.00 | 0.00 |
XTANT MED HLDGS INCSOLE | COM NEW | 7.42M | SH | $4.67M 1.91% | 7.42M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 50K | SH | $4.03M 1.64% | 50K | 0.00 | 0.00 |
THE REALREAL INCSOLE | COM | 1.25M | SH | $3.99M 1.63% | 1.25M | 0.00 | 0.00 |
CYBIN INCSOLE | COM | 13.95M | SH | $3.78M 1.54% | 13.95M | 0.00 | 0.00 |
OUTLOOK THERAPEUTICS INCSOLE | COM | 501.79K | SH | $3.70M 1.51% | 501.79K | 0.00 | 0.00 |
Page 1 of 3